Key facts
- BioLumic’s last known valuation is $69.0M (Apr 2025).
- It has raised $32.6M across 2 recorded rounds; the latest was Early Stage VC ($12.5M) in Mar 2022.
- Notable investors include OurCrowd, Icehouse Ventures, iSelect Fund, Azolla Ventures, Enterprise Angels — 34 tracked in total.
- BioLumic has filed 2 Form Ds with the SEC since 2021, most recently Mar 2022 ($12.5M sold to 25 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 34 names
- ·Watchlist + deal alerts for BioLumic
Funding rounds
2 roundsAbout BioLumic
Developer of an ultraviolet crop improvement system designed to address growing agricultural concerns. The company's systems utilize ultraviolet radiation, which can regulate numerous responses in living organisms and apply it to young plants, priming them to thrive and survive, enabling farmers to increase crop yields, fungal resistance in transplant seedlings, and improve color and taste in indoor-grown products.
- Sector
- Materials and Resources
- HQ
- Palmerston North, New Zealand
- Founded
- 2012
- Employees
- 35
- Website
- biolumic.com/
- Ownership
- Privately Held (backing)
BioLumic doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioLumic shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioLumic in its N-PORT filings yet. We sweep new filings monthly.